In our study, by mimicking the crosstalk with mast cells we found that GEM/NAB promotes the release of TGF-β1 from tumor cells, and we suggested that in cells in which a functional interplay between TGF-β1 and PAR-2 signalling occurs, resistance to GEM/NAB develops. The gene discussed is F2RL1; the disease is neoplasm.